MSK researchers shed new light on G-quadruplexes, a type of secondary DNA structure that has attracted attention as a ...

The U.S. Food and Drug Administration has approved vimseltinib for adult patients with a rare condition called tenosynovial ...

Research at MSK Our research impact Research topics Core facilities & resources ...

Our research group is interested in understanding, at the structural and mechanistic levels, the maintenance of genomic integrity and the control of cell growth, both of which figure prominently in ...

U.S. health officials have expanded the recommended age range for people receiving the HPV vaccine to protect against several types of cancer to people in their mid-40s. MSK physicians offers advice ...

Dr. Vinod Balachandran says mRNA vaccines could stimulate the immune system to recognize and attack pancreatic cancer cells. An experimental approach to treating pancreatic cancer with the messenger ...

Research at MSK Our research impact Research topics Core facilities & resources ...

Research at MSK Our research impact Research topics Core facilities & resources ...

Ready to start planning your care? Call us at 800-525-2225 to make an appointment.

Research at MSK Our research impact Research topics Core facilities & resources ...

Cancer remains the leading driver of healthcare costs for employers, with a significant rise in cases among people under 50. 1, 2 MSK Direct addresses this challenge, helping benefits leaders ...

Research at MSK Our research impact Research topics Core facilities & resources ...